- Home
- QUBT vs BRNS Comparison
QUBT vs BRNS Comparison
Compare QUBT & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QUBT
- BRNS
- Stock Information
- Founded
- QUBT 2001
- BRNS 2016
- Country
- QUBT United States
- BRNS United Kingdom
- Employees
- QUBT 50
- BRNS N/A
- Industry
- QUBT Computer Manufacturing
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- QUBT Technology
- BRNS Health Care
- Exchange
- QUBT Nasdaq
- BRNS Nasdaq
- Market Cap
- QUBT 2.7B
- BRNS 36.0M
- IPO Year
- QUBT N/A
- BRNS 2021
- Fundamental
- Price
- QUBT $20.72
- BRNS $1.00
- Analyst Decision
- QUBT Buy
- BRNS Strong Buy
- Analyst Count
- QUBT 2
- BRNS 1
- Target Price
- QUBT $18.50
- BRNS $3.00
- AVG Volume (30 Days)
- QUBT 40.2M
- BRNS 11.5K
- Earning Date
- QUBT 05-15-2025
- BRNS 08-07-2025
- Dividend Yield
- QUBT N/A
- BRNS N/A
- EPS Growth
- QUBT N/A
- BRNS N/A
- EPS
- QUBT N/A
- BRNS N/A
- Revenue
- QUBT $385,000.00
- BRNS $14,969,000.00
- Revenue This Year
- QUBT $91.42
- BRNS N/A
- Revenue Next Year
- QUBT $114.29
- BRNS N/A
- P/E Ratio
- QUBT N/A
- BRNS N/A
- Revenue Growth
- QUBT 45.83
- BRNS 4381.74
- 52 Week Low
- QUBT $0.45
- BRNS $0.64
- 52 Week High
- QUBT $27.15
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- QUBT 65.62
- BRNS 53.30
- Support Level
- QUBT $16.39
- BRNS $0.90
- Resistance Level
- QUBT $20.94
- BRNS $0.94
- Average True Range (ATR)
- QUBT 1.90
- BRNS 0.05
- MACD
- QUBT -0.01
- BRNS 0.00
- Stochastic Oscillator
- QUBT 79.87
- BRNS 96.80
About QUBT Quantum Computing Inc.
Quantum Computing Inc is an integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines to the world today. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.